Advanced Prostate Cancer VL

How to Treat Men With Newly Diagnosed cN1 cM0 Prostate Cancer - Systemic Therapy Options - Nicholas James

Details
Nick James presented on the systemic therapy options for men with node-positive hormone-sensitive prostate cancer (HSPC), including whether the primary tumor should be treated, and which treatments can be combined at the 2019 Advanced Prostate Cancer Consensus Conference (APCCC). Also highlighted in his presentation is the role of docetaxel in M0 and M1 HSP, abiraterone’s role in high-risk M0 HSPC...

Management of Men With PSA Recurrence or Persistence After Prostatectomy: Presentation - Christopher Evans

Details
Christopher Evans, Professor and Chair, Department of Urologic Surgery at UC-Davis discussed the management of men with PSA recurrence or persistence after radical prostatectomy during the Advanced Prostate Cancer Consensus Conference (APCCC) 2019 session on PSA recurrence after radical local therapy and oligometastatic prostate cancer. He followed Dr. Felix Feng's presentation on PSA Recurrence a...

Management of Men with PSA Recurrence After Radical Local Radiation Therapy Presentation - Felix Feng

Details
Felix Feng presented during the PSA Recurrence after Radical Local Therapy and Oligometastatic Prostate Cancer session at the 2019 Advanced Prostate Cancer Consensus Conference (APCCC). He focused on the topic of management of men with PSA recurrence after radical local radiation therapy. Of the 1.2 million-plus patients that are diagnosed with prostate cancer each year worldwide, in the United St...

Disparities in Prostate Cancer Management in the United States Presentation - Alicia Morgans

Details
At the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) Dr. Alicia Morgans presented on disparities in prostate cancer management in the United States. Dr. Morgans highlights the 174,650 new cases of prostate cancer in the United States in 2019 and noting that social health is determined by many factors which could be responsible for these disparities, she frames her discussion around wh...

Pharmaco-ethnicity and Its Impact on Treatment Presentation - Darren MC Poon

Details
At the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) Darren Poon gave an overview of prostate cancer in the East-Asian ethnicity. This ethnicity includes China, (including Hong-Kong and Macau), Japan, Mongolia, North Korea, South Korea, and Taiwan. When assessing the taxane related adverse events in Asian prostate cancer patients, compared to the rates described in the major studies,...

APCCC 2019 Global vs. Expert Consensus in the Management of Advanced Prostate Cancer Study - Charles Ryan

Details
Charles Ryan and Alicia Morgans encourage participation in a 6 minute (survey) study available on UroToday.com, titled the Global vs. Expert Consensus in the Management of Advanced Prostate Cancer Study , a questionnaire intended to determine the global consensus among all physicians treating patients with advanced prostate cancer. The aim is to further understand global patterns of care in advanc...

Clinical Utility of Molecular Biomarkers Presentation - Johann de Bono

Details
Professor de Bono presents the clinical utility of predictive molecular biomarkers in advanced prostate cancer during the first session of the Advanced Prostate Cancer Consensus Conference (APCCC 2019). Biographies: Johann de Bono, MB ChB FRCP MSc Ph.D. FMedSci. Professor Johann de Bono is Regius Professor of Cancer Research and a Professor in Experimental Cancer Medicine at The Institute of Cance...

Baseline PSA Level in Midlife and Aggressive Prostate Cancer in African American Men - Mark Preston

Details
Alicia Morgans and Mark Preston share a discussion on his recent paper Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men published in European Urology which set to determine whether baseline PSA level during midlife predicts the risk of aggressive prostate cancer in African American men. They also discuss whether the baseline PSAs could correlate with...

Optimizing Care in Localized Prostate Cancer - Mary-Ellen Taplin and Adam Kibel

Details
Adam Kibel and Mary-Ellen Taplin join Alicia Morgans in a conversation about optimizing the care of men with localized prostate cancer, both systemic therapy, and surgical techniques and a combination of the two. They discuss the treatment landscape and their insights into what the field could consider for patients with localized disease. Biographies: Adam Kibel, MD, Chief, Division of Urology Ell...

Latin American Oncology Group (LACOG), a Cooperative Group Consensus - Fernando Maluf

Details
Charles Ryan is joined by Fernando Maluf, leader of genitourinary oncology in Brazil, who shares details on the upcoming Latin American Oncology Group (LACOG), a cooperative group consensus meeting. This cooperative group, developed a consensus to strive for answers on screening for late stage of prostate cancer, from the experts from all over the world particularly for developing countries in Afr...
email news signup